MSA
BMRN icon

Mason Street Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Mason Street Advisors’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-288,247
Closed -$26.1M – 1542
2014
Q4 		$26.1M Buy
288,247
+27,191
+10% +$2.26M 0.18% 127
2014
Q3 		$18.8M Sell
261,056
-4,256
-2% -$280K 0.15% 170
2014
Q2 		$16.5M Sell
265,312
-8,261
-3% -$499K 0.13% 197
2014
Q1 		$18.7M Sell
273,573
-490
-0.2% -$36.1K 0.15% 183
2013
Q4 		$19.3M Buy
274,063
+97,129
+55% +$6.6M 0.16% 167
2013
Q3 		$12.8M Buy
176,934
+152,894
+636% +$10.2M 0.15% 190
2013
Q2 		$1.34M Buy
+24,040
New +$1.5M 0.01% 817

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return